M754-1925 Screening compound: 3-(5-{1-[3-(trifluoromethyl)benzenesulfonyl]piperidin-2-yl}-4H-1,2,4-triazol-3-yl)pyridine

M754-1925 Screening compound: 3-(5-{1-[3-(trifluoromethyl)benzenesulfonyl]piperidin-2-yl}-4H-1,2,4-triazol-3-yl)pyridine
M754-1925 Screening compound: 3-(5-{1-[3-(trifluoromethyl)benzenesulfonyl]piperidin-2-yl}-4H-1,2,4-triazol-3-yl)pyridine alternative view

Chemical Structure Depiction of ChemDiv screening compound M754-1925
3-(5-{1-[3-(trifluoromethyl)benzenesulfonyl]piperidin-2-yl}-4H-1,2,4-triazol-3-yl)pyridine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M754-1925

Molecular Formula

C19H18F3N5O2S (C19 H18 F3 N5 O2 S)

Compound Name

3-(5-{1-[3-(trifluoromethyl)benzenesulfonyl]piperidin-2-yl}-4H-1,2,4-triazol-3-yl)pyridine

IUPAC name

3-(5-{1-[3-(trifluoromethyl)benzenesulfonyl]piperidin-2-yl}-4H-124-triazol-3-yl)pyridine

SMILES

O=S(c1cc(C(F)(F)F)ccc1)(N(CCCC1)C1c1nnc(-c2cnccc2)[nH]1)=O

InChI

InChI=1S/C19H18F3N5O2S/c20-19(21,22)14-6-3-7-15(11-14)30(28,29)27-10-2-1-8-16(27)18-24-17(25-26-18)13-5-4-9-23-12-13/h3-7,9,11-12,16H,1-2,8,10H2,(H,24,25,26)/t16-/m0/s1

InChI Key

DWLIBJYFBICQCX-INIZCTEOSA-N

MDL Number (MFCD)

MFCD31956239

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.45

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.772

Distribution Coefficient, logD

2.667

Water Solubility, LogSw

-3.10

Polar Surface Area

75.451

Acid Dissociation Constant (pKa)

3.91

Base Dissociation Constant (pKb)

6.67

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

31.58

M754-1925 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

CNS Targets (44014 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with M754-1925 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M754-1925?
Check Price and Availability of M754-1925, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M754-1925 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M754-1925
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M754-1925
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M754-1925 available by request